MedWatch

RSP Systems raises millions for launch of non-invasive blood glucose meter

The Danish medtech company RSP Systems has secured nearly DKK 50 million through fundraising. However, the goal is to raise three times as much in order to launch a non-invasive blood glucose meter in Europe by the beginning of 2020, according to the company's CSO and former CEO.

Danish RSP Systems hopes to be able to launch a non-invasive blood glucose meter by 2020. | Foto: /ritzau/Kristian Djurhuus

The medtech company RSP Systems, which was founded in 2006 as a spin-out from University of Southern Denmark (SDU), has just closed the first part of a Series B financing round and has secured nearly DKK 50 million (USD 7.9 million) for the continued operations of the company.

The company has thereby secured funding for the next year or so. However, RSP Systems expects to expand the financing round significantly in order to get to commercialization with a product, says the company's CSO Anders Weber to MedWatch.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier